Literature DB >> 23543090

A Study on the Correlation between Cord Blood Glucose Level and the Apgar Score.

Kalyan Khan1, Ashis Ranjan Saha.   

Abstract

INTRODUCTION: The study of the biochemical parameters of cord blood acts as a mirror, which usually reflects the neonatal status. The widely used system for the evaluation of a neonate is the Apgar score. There is no comprehensive published data which has established the association between the cord blood glucose level and the Apgar score. Similarly, there is also no well accepted reference range of the cord blood glucose level.
OBJECTIVES: The main objectives of the present study was to ascertain any adverse effects of an abnormal cord blood glucose level on the neonatal status and to find out a standard reference level of glucose in cord blood.
METHODS: The cord blood glucose estimation was done by using the glucose oxidase peroxidase method and the statistical analysis was performed by using the SPSS, version 16 software. RESULTS AND
CONCLUSIONS: In the present study, the cord blood glucose level was found to have no correlation with the Apgar scores which were calculated at both one minute and five minutes after birth. It was also found that for the foetus to be free from any obvious complication, the cord blood glucose level had to be around 87 mg/dl. The fluctuations in the maternal glucose levels are weakly associated with the glucose level in the cord blood.

Entities:  

Keywords:  Apgar score; Cord blood; Glucose level; Neonatal status

Year:  2013        PMID: 23543090      PMCID: PMC3592299          DOI: 10.7860/JCDR/2013/4942.2754

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  The continuing value of the Apgar score for the assessment of newborn infants.

Authors:  B M Casey; D D McIntire; K J Leveno
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Evaluation of the newborn infant; second report.

Authors:  V APGAR; D A HOLADAY; L S JAMES; I M WEISBROT; C BERRIEN
Journal:  J Am Med Assoc       Date:  1958-12-13

3.  A proposal for a new method of evaluation of the newborn infant.

Authors:  V APGAR
Journal:  Curr Res Anesth Analg       Date:  1953 Jul-Aug

4.  Pregnancy outcome in primiparae of advanced maternal age.

Authors:  Ilse Delbaere; Hans Verstraelen; Sylvie Goetgeluk; Guy Martens; Guy De Backer; Marleen Temmerman
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-11-22       Impact factor: 2.435

5.  Neonatal blood glucose concentrations in caesarean and vaginally delivered term infants.

Authors:  Ronella Marom; Shaul Dollberg; Francis B Mimouni; Irit Berger; Nina Mordechayev; Yifat Ochshorn; Dror Mandel
Journal:  Acta Paediatr       Date:  2010-10       Impact factor: 2.299

6.  Screening of foetal distress by assessment of umbilical cord lactate.

Authors:  F Borruto; C Comparetto; E Wegher; A Treisser
Journal:  Clin Exp Obstet Gynecol       Date:  2006       Impact factor: 0.146

7.  Correlation between foetal pH, cord blood glucose level and Apgar score in a foetal intensive care unit--preliminary report.

Authors:  M O Sogbanmu; B Ajani
Journal:  Afr J Med Med Sci       Date:  1978-03

8.  Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study.

Authors:  Christos S Mantzoros; Sheryl L Rifas-Shiman; Catherine J Williams; Jessica L Fargnoli; Theodoros Kelesidis; Matthew W Gillman
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

9.  4 million neonatal deaths: when? Where? Why?

Authors:  Joy E Lawn; Simon Cousens; Jelka Zupan
Journal:  Lancet       Date:  2005 Mar 5-11       Impact factor: 79.321

  9 in total
  1 in total

1.  Study of Complete Haemogram and Iron Profile From Cord Blood of Newborn with Respect to Primigravida, Multigravida and Apgar Score.

Authors:  Madhumita Mondal; Swapan Kumar Sinha; Moumita Sengupta; Debdas Bose; Sudip Saha; Utpal Chaudhuri
Journal:  Indian J Hematol Blood Transfus       Date:  2017-08-23       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.